Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extension

Published:2024-08 Issue: Volume:74 Page:102732
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Röth Alexander,Broome Catherine M.,Barcellini Wilma,Jilma Bernd,Hill Quentin A.,Cella David,Anderson Tvedt Tor Henrik,Yamaguchi Masaki,Murakhovskaya Irina,Lee Michelle,Shafer Frank,Wardęcki Marek,Jayawardene Deepthi,Yoo Ronnie,Msihid Jerome,Weitz Ilene C.

Funder

Sanofi

Publisher

Elsevier BV

Reference29 articles.

1. New insights in the pathogenesis and therapy of cold agglutinin-mediated autoimmune hemolytic anemia;Berentsen;Front Immunol,2020

2. Novel insights into the treatment of complement-mediated hemolytic anemias;Berentsen;Ther Adv Hematol,2019

3. Complementopathies;Baines;Blood Rev,2017

4. Cold agglutinin disease;Berentsen;Hematol Am Soc Hematol Educ Program,2016

5. Incidence of thromboembolic events is increased in a retrospective analysis of a large cold agglutinin disease (CAD) cohort;Broome;Blood,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP